Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Pfizer’s Talzenna combo moves up treatment line with FDA nod
Pfizer’s Talzenna moves into an earlier prostate cancer treatment setting after an FDA nod backed by a 52% reduction in progression or death.
Donavyn Coffey
Oct 26, 2026 3:27pm
Merck sees ‘pretty consistent’ data in sac-TMT’s 1st global ph. 3
Oct 26, 2026 11:30am
Why AI’s Biggest Value in Pharma Is Confidence
Brought to you by
/prompt
Rhapsido ph. 3 in MS combines superior safety with strong efficacy
Oct 26, 2026 11:05am
Clinical trials reach a new automation inflection point
Brought to you by
IQVIA
Bristol CMO touts more ph. 3 wins for bispecific ADC iza-bren
Oct 26, 2026 3:30am
